Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 27;2(2):199-213.
doi: 10.1002/epi4.12050. eCollection 2017 Jun.

Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil

Shaloo Gupta  1 , Philippe Ryvlin  2 , Edward Faught  3 , Wan Tsong  4 , Patrick Kwan  5
Affiliations

Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil

Shaloo Gupta et al. Epilepsia Open. .

Abstract

Objective: To understand the current burden of focal epilepsy (FE) as a function of seizure frequency.

Methods: Patients were identified from the United States (2011, 2012, and 2013), five European countries (EU; France, Germany, Italy, Spain, United Kingdom) (2011 and 2013), and Brazil (2011 and 2012) National Health and Wellness Survey (NHWS), a nationally representative, Internet-based survey of adults (18+ years). The NHWS collected data on respondents' quality of life (QoL), health utilities, productivity loss, and healthcare resource utilization. Indirect and direct costs were calculated from the literature. Altogether, 345 of 176,093 (U.S.A.), 73 of 30,000 (United Kingdom), 53 of 30,001 (Germany), 53 of 30,000 (France), 41 of 12,011 (Spain), 37 of 17,500 (Italy), and 71 of 24,000 (Brazil) respondents self-reported a diagnosis of FE.

Results: Many respondents (U.S.A.: 56.2%; 5EU: 41.6%; Brazil + 5EU: 40.5%) reported persistent seizures (≥1 per year). Over 60% to just over 71% of respondents with FE were treated with antiepileptic drugs (AEDs). In the United States, seizure frequency was associated with hospitalizations, indirect costs (ages 18-60), and total direct costs. For the 5EU and Brazil + 5EU, seizure frequency was associated with physical QoL, health utilities, activity impairment, and emergency room (ER) visits. Additional associations were observed for the 5EU on hospitalizations, indirect costs (ages 18-60), ER visit costs, and total direct costs and for Brazil + 5EU on absenteeism, overall work impairment, and provider visits. Costing was not performed for Brazil + 5EU.

Significance: Around half of the patients had persistent seizures despite most taking an AED in this 2011-2013 dataset. The results support the hypothesis that reducing seizures can improve productivity and reduce resource utilization and associated costs. Regional differences may reflect differences in healthcare systems and selected patient populations. Overall, the results suggest that additional treatment options are needed to improve seizure control and reduce related costs.

Keywords: Costs; Health utilities; Productivity; Quality of life; Resource utilization.

PubMed Disclaimer

References

    1. Picot MC, Baldy‐Moulinier M, Daurès JP, et al. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population‐based study in a Western European country. Epilepsia 2008;49:1230–1238. - PubMed
    1. Torres‐Ferrús M, Toledo M, González‐Cuevas M, et al. [Aetiology and treatment of epilepsy in a series of 1,557 patients]. Rev Neurol 2013;57:306–312. - PubMed
    1. Taylor RS, Sander JW, Taylor RJ, et al. Predictors of health‐related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia 2011;52:2168–2180. - PubMed
    1. Baker GA, Gagnon D, McNulty P. The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res 1998;30:231–240. - PubMed
    1. Hong Z, Qu B, Wu XT, et al. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China. Epilepsia 2009;50:2192–2198. - PubMed

LinkOut - more resources